Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,694.00p
   
  • Change Today:
    -11.00p
  • 52 Week High: 1,885.00
  • 52 Week Low: 1,135.00
  • Currency: UK Pounds
  • Shares Issued: 135.92m
  • Volume: 317,493
  • Market Cap: £2,302.43m
  • RiskGrade: 314

Indivior shares tumble as group sets aside $290m for US litigation

By Iain Gilbert

Date: Thursday 16 Feb 2023

LONDON (ShareCast) - (Sharecast News) - Shares in pharmaceuticals business Indivior tumbled early on Thursday after the group revealed it had put aside $290.0m for ongoing litigation in the States.
Indivior stated the money was intended to cover "multidistrict antitrust class and state claims" and follows legal action over the firm's attempts to delay competition to its best-selling addiction treatment product Suboxone.

"The provision is the group's estimate at this time of a potential aggregate settlement," said Indivior.

"However, the group cannot predict with any certainty whether Indivior Inc will reach a settlement with any of the plaintiffs, and the final aggregate cost of these matters, whether resolved by settlement or trial, may be materially different."

In terms of earnings, Indivior posted a 14% uptick in full-year revenues to $901.0m, with fourth-quarter revenues rising 9% to $241.0m. Adjusted operating profits came to $212.0m in 2022, up 13% from the previous year.

The FTSE 250-listed firm added that total net revenue for 2023 was expected to be between $950.0m and $1.02bn.

As of 0845 GMT, Indivior shares had slumped 12.45% at 1,710.80p.









Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,694.00p
Change Today -11.00p
% Change -0.65 %
52 Week High 1,885.00
52 Week Low 1,135.00
Volume 317,493
Shares Issued 135.92m
Market Cap £2,302.43m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.63% below the market average54.63% below the market average54.63% below the market average54.63% below the market average54.63% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Price Trend
66.63% above the market average66.63% above the market average66.63% above the market average66.63% above the market average66.63% above the market average
85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average
Income Not Available
Growth
50.53% above the market average50.53% above the market average50.53% above the market average50.53% above the market average50.53% above the market average
8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average8.11% below the sector average

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:38 45,765 @ 1,704.19p
16:36 358 @ 1,694.00p
16:35 211,291 @ 1,694.00p
16:35 858 @ 1,694.00p
16:35 145 @ 1,694.00p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page